BioCryst Announces Approval of ORLADEYO® (berotralstat) by the National Administration of Drugs, Foods, and Medical Devices (ANMAT) in Argentina
Источник:
Nasdaq GlobeNewswire
/
29 ноя 2023 07:00:00 America/New_York
N/A
Опубликовать